ESMO: European Society for Medical Oncology

  1. The results of KEYNOTE-158 study
  2. Researchers uncover how immune checkpoint inhibitor response relies on the evolved efficiency of HLA-mediated immunity
  3. Evidence for efficacy is based on the results from the BELIEVE trial
  4. Detection and management strategies
  5. The results of the AcSé phase II study